Literature DB >> 25155948

Validation of a novel radiographic scoring system for calcinosis affecting the hands of patients with systemic sclerosis.

Lorinda Chung1, Antonia Valenzuela, David Fiorentino, Kathryn Stevens, Shufeng Li, Jonathan Harris, Charles Hutchinson, Shervin Assassi, Lorenzo Beretta, Santhanam Lakshminarayanan, Tatiana S Rodriguez-Reyna, Christopher P Denton, Rebecca G Taillefer, Ariane L Herrick, Murray Baron.   

Abstract

OBJECTIVE: There are currently no validated outcome measures to assess calcinosis severity in systemic sclerosis (SSc; scleroderma). We sought to develop and validate a novel radiographic scoring system for calcinosis affecting the hands of SSc patients for potential use in future clinical trials.
METHODS: Following a 1-hour teleconference training session, 12 investigators (8 rheumatologists, 1 dermatologist, and 3 radiologists) scored 12 hand radiographs in random order using 2 scoring systems (termed “simple” and “complex”) and re-scored 2 randomly assigned radiographs after a minimum of 24 hours. Interrater and intrarater reliability were assessed using a weighted kappa coefficient for the simple system (κ), and an intraclass correlation coefficient (ICC) for the complex system (ICC <0.4 for poor, 0.4–0.7 for moderate, and >0.7 for excellent).
RESULTS: Mean time to complete the complex scoring system was significantly longer than the simple scoring system (4.0 versus 0.4 minutes; P < 0.0001). Overall interrater reliability for the simple scoring system was poor (κ = 0.39, 95% confidence interval [95% CI] 0.1–0.52) but improved if dichotomized as mild/moderate versus severe (κ = 0.51, 95% CI 0.26–0.7). Interrater reliability was excellent for the complex scoring system (ICC 0.89, 95% CI 0.86–0.92). Intrarater reliability was moderate for the simple scoring system (κ = 0.67, 95% CI 0.37–0.96) but almost perfect for the complex scoring system (ICC 0.93, 95% CI 0.89–0.97).
CONCLUSION: We developed a novel radiographic scoring system that accounts for the area coverage, density, and anatomic location of calcinosis affecting the hands in patients with SSc. This scoring system is feasible with excellent reliability and should undergo further validation testing for use in clinical trials.

Entities:  

Mesh:

Year:  2015        PMID: 25155948     DOI: 10.1002/acr.22434

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  10 in total

Review 1.  Subcutaneous calcinosis: Is it different between systemic sclerosis and dermatomyositis?

Authors:  Antonia Valenzuela; Lorinda Chung
Journal:  J Scleroderma Relat Disord       Date:  2021-10-28

2.  The impact of skin calcinosis on digital ulcers in patients with SSc: clinical and prognostic stratification using the "wound bed score".

Authors:  Simone Barsotti; Valentina Venturini; Marco Di Battista; Agata Janowska; Valentina Dini; Alessandra Della Rossa; Marta Mosca
Journal:  Int Wound J       Date:  2020-09-14       Impact factor: 3.315

3.  Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study.

Authors:  Antonia Valenzuela; Murray Baron; Ariane L Herrick; Susanna Proudman; Wendy Stevens; Tatiana S Rodriguez-Reyna; Alessandra Vacca; Thomas A Medsger; Monique Hinchcliff; Vivien Hsu; Joy Y Wu; David Fiorentino; Lorinda Chung
Journal:  Semin Arthritis Rheum       Date:  2016-06-02       Impact factor: 5.532

4.  Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis.

Authors:  Antonia Valenzuela; Murray Baron; Tatiana S Rodriguez-Reyna; Susanna Proudman; Dinesh Khanna; Amber Young; Monique Hinchcliff; Virginia Steen; Jessica Gordon; Vivien Hsu; Flavia V Castelino; Sara Schoenfeld; Shufeng Li; Joy Y Wu; David Fiorentino; Lorinda Chung
Journal:  Semin Arthritis Rheum       Date:  2020-06-17       Impact factor: 5.532

5.  An Interim Report of the Scleroderma Clinical Trials Consortium Working Groups.

Authors:  Murray Baron; Bashar Kahaleh; Elana J Bernstein; Lorinda Chung; Philip J Clements; Christopher Denton; Robyn T Domsic; Nava Ferdowsi; Ivan Foeldvari; Tracy Frech; Jessica K Gordon; Marie Hudson; Sindhu R Johnson; Dinesh Khanna; Zsuzsannah McMahan; Peter A Merkel; Sonali Narain; Mandana Nikpour; John D Pauling; Laura Ross; Antonia Maria Valenzuela Vergara; Alessandra Vacca
Journal:  J Scleroderma Relat Disord       Date:  2018-07-18

6.  Ultrasound Detection of Calcinosis and Association With Ulnar Artery Occlusion in Patients With Systemic Sclerosis.

Authors:  Robert Fairchild; Melody Chung; Laurel Sharpless; Shufeng Li; Lorinda Chung
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-07-27       Impact factor: 5.178

7.  Use of dual-energy computed tomography for the evaluation of calcinosis in patients with systemic sclerosis.

Authors:  Vivien Hsu; Mark Bramwit; Naomi Schlesinger
Journal:  Clin Rheumatol       Date:  2015-07-03       Impact factor: 2.980

8.  Reliability and Validity of the Medical Outcomes Study Short Form-12 Version 2 (SF-12v2) in Adults with Non-Cancer Pain.

Authors:  Corey J Hayes; Naleen Raj Bhandari; Niranjan Kathe; Nalin Payakachat
Journal:  Healthcare (Basel)       Date:  2017-04-26

9.  Computer vision applied to dual-energy computed tomography images for precise calcinosis cutis quantification in patients with systemic sclerosis.

Authors:  Anita C Chandrasekaran; Zhicheng Fu; Reid Kraniski; F Perry Wilson; Shannon Teaw; Michelle Cheng; Annie Wang; Shangping Ren; Imran M Omar; Monique E Hinchcliff
Journal:  Arthritis Res Ther       Date:  2021-01-06       Impact factor: 5.156

10.  Relationship between calcifications and structural lesions on hand radiography and axial calcifications on CT-scan: A retrospective study in systemic sclerosis.

Authors:  Elodie Bauer; Marine Fauny; Maurice Tanguy; Eliane Albuisson; Damien Mandry; Olivier Huttin; Francois Chabot; Joelle Deibener; Isabelle Chary-Valckenaere; Damien Loeuille
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.